SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-14-048832
Filing Date
2014-06-27
Accepted
2014-06-27 06:00:19
Documents
4
Period of Report
2014-06-26
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 5.07: Submission of Matters to a Vote of Security Holders
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K a14-15988_18k.htm 8-K 78298
2 EX-3.1 a14-15988_1ex3d1.htm EX-3.1 98332
3 EX-10.1 a14-15988_1ex10d1.htm EX-10.1 46511
4 EX-99.1 a14-15988_1ex99d1.htm EX-99.1 6447
  Complete submission text file 0001104659-14-048832.txt   231083
Mailing Address 1040 SPRING ST SILVER SPRING MD 20910
Business Address 1040 SPRING ST SILVER SPRING MD 20910 3016089292
UNITED THERAPEUTICS Corp (Filer) CIK: 0001082554 (see all company filings)

IRS No.: 521984749 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-26301 | Film No.: 14944037
SIC: 2834 Pharmaceutical Preparations